Welcome to our dedicated page for Altice Usa SEC filings (Ticker: ATUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to pinpoint subscriber growth, debt leverage or network-upgrade costs buried in Altice USA’s 200-page filings? Telecom disclosures are dense, and Altice’s mix of broadband, wireless, advertising and news operations makes each line item even harder to untangle.
Stock Titan’s AI reads every Altice USA annual report 10-K simplified, Altice USA quarterly earnings report 10-Q filing and Altice USA 8-K material events explained the moment they hit EDGAR. Our platform converts legal jargon into plain English, highlights segment revenue from Optimum and Suddenlink, and flags capital-expenditure notes on the Lightpath fiber rollout. Need Altice USA insider trading Form 4 transactions? You’ll see Altice USA Form 4 insider transactions real-time, complete with instant alerts. Our AI-powered summaries answer questions investors actually ask, like “What changed in Altice USA executive compensation proxy statement?” or “How did advertising margins shift this quarter?”
Whether you’re monitoring Altice USA executive stock transactions Form 4 before earnings, comparing churn metrics across filings, or seeking Altice USA earnings report filing analysis for valuation models, everything is here in one place—updated in real time, explained simply, and searchable by keyword. Stop downloading PDFs and start understanding Altice USA SEC filings explained simply with AI.
Abbott Laboratories (ABT) – Form 4 Insider Transaction
Director John G. Stratton reported the routine crediting of 282 Stock Equivalent Units to his deferred fee account on 30 Jun 2025. These units mirror the performance of Abbott common shares and are settled in cash, generally when the director turns 65 or retires from the board. The units were valued at $136.01 each, matching the share price reference on the transaction date. Following the credit, Stratton now beneficially owns 12,315 stock-equivalent units. No open-market purchase or sale of Abbott common stock occurred; the transaction represents non-derivative compensation for board service and therefore has no immediate cash outflow by the insider.
The filing does not disclose any changes in ordinary share ownership, option exercises, or derivative disposals. Given Abbott’s market capitalization and daily trading volume, the addition of 282 units is immaterial to overall share supply and is largely administrative, but it does marginally increase the director’s economic alignment with shareholders.
Millennium Management LLC, along with affiliated entities, has reported acquiring a significant stake in Altice USA through a Schedule 13G filing. The investment group collectively holds 14,377,609 shares, representing a 5.1% ownership in the company's Class A Common Stock.
Key details of the filing:
- Three reporting entities: Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander
- All shares are held with shared voting and dispositive power
- Filing date: June 28, 2025
- Event date triggering filing: June 12, 2025
- Securities were not acquired to influence or change control of the issuer
The filing indicates a passive investment strategy, as confirmed by the certification that the shares were not acquired to influence company control. The three reporting entities maintain their principal business offices at 399 Park Avenue, New York, with Israel A. Englander serving as the sole voting trustee of Millennium Group Management LLC, which is the managing member of Millennium Management LLC.